Entities / Entity
bioMérieux.
French company specialised in in vitro diagnostics
- Reports this week
- 0
- Active events
- 0
- Connections
- 33
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
T2S Group Holding, Morocco's largest integrated medical technology company, announced partnerships and began trading on the Casablanca Stock Exchange.Well supported5 reports
-
bioMérieux developed a new assay for species identity verification and offered expert opinion on challenges facing the probiotic industry.Some support1 report
-
Morgan Stanley downgraded bioMérieux shares on July 7, 2026.Some support2 reports
-
Jay Patel discussed quality standards for analytical services involving bioMérieux.Some support1 report
-
Rwanda acquired advanced diagnostic machines from bioMérieux on July 1, 2026.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around bioMérieux this week
News at the entities that move bioMérieux most-
Morgan Stanley TransactionalFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves bioMérieux
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves bioMérieux
-
Uganda Shared contextAllegations of border issues involving election materials are reported between Uganda and Kenya.Moves bioMérieux
-
Rwanda TransactionalNSSF invests in regional equities and debt, focusing on financial markets across East and Central Africa.Moves bioMérieux
-
Democratic Republic of the Congo Shared contextRecent health center attacks occurred near Butembo in the Democratic Republic of the Congo.Moves bioMérieux
Connections
The 6 strongest of 33, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Morgan Stanley Transactional
Morgan Stanley downgraded bioMérieux shares and rating.
-
FDA Structural
The FDA granted approval for a test panel produced by bioMérieux in 2023, establishing a formal regulatory dependency.
-
Jay Patel Structural
A provides analytical services that are integrated into and influence bioMérieux's quality standards and operations.
-
Rwanda Transactional
Rwanda acquired advanced diagnostic machines from bioMérieux.
-
Uganda Shared context
bioMérieux operates in Uganda, driven by high demand resulting from current outbreaks.
-
Democratic Republic of the Congo Shared context
BioMérieux's demand is driven by current health outbreaks occurring within the Democratic Republic of the Congo.
History
Events by the month they beganJuly 2026
5 events- T2S Group Holding, Morocco's largest integrated medical technology company, announced partnerships and began trading on the Casablanca Stock Exchange.
- bioMérieux developed a new assay for species identity verification and offered expert opinion on challenges facing the probiotic industry.
- Morgan Stanley downgraded bioMérieux shares on July 7, 2026.
- Jay Patel discussed quality standards for analytical services involving bioMérieux.
- Rwanda acquired advanced diagnostic machines from bioMérieux on July 1, 2026.